A new weight-loss shot helps people lose a lot of weight and feel better

Original Title

Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This study looked at a new medicine called retatrutide that you inject once a week. It helped people with extra weight or diabetes lose a lot of weight, lower their blood sugar, and reduce blood pressure.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Retatrutide increased the likelihood of losing 20% or more of body weight by 16.6 times compared to placebo — even higher than the 15% threshold.

Most weight-loss drugs rarely push people past 10–15% loss; hitting 20% is usually only seen with bariatric surgery. This drug is approaching surgical-level results without surgery.

Practical Takeaways

If you have obesity or type 2 diabetes, ask your doctor if you’re a candidate for upcoming retatrutide trials — it may be your best shot at major weight loss without surgery.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

69%
Moderate QualityOverall Score

Publication

Journal

Metabolism Open

Year

2024

Authors

E. Pasqualotto, R. Ferreira, M. Chavez, Alexandre Hohl, M. Ronsoni, Tales Pasqualotto, F. A. Moraes, L. Hespanhol, Janine Midori Figueiredo Watanabe, Carine Lütkemeyer, Simone van de Sande-Lee

Open Access
8 citations
Analysis v1